The aim of this study was to isolate stem cells from osteopenic rats, and to investigate and compare their cluster of differentiation marker expression, proliferation, migration, osteogenic, and adipogenic differentiation potential. The hypothesis of this study is that these characteristics will differ between mesenchymal stem cells (MSCs) harvested from young, adult, and ovariectomized rats.
The study would benefit from further investigation of the underlying mechanisms that reduce differentiating capacity and C-X-C chemokine receptor type 4 (CXCR-4) expression from cells derived from osteopenic animals, and from resultantly addressing the potential link with age-related deficits in bone repair. introduction osteoporosis causes over 8.9 million fractures annually worldwide; characterized by loss of trabecular architecture and bone mass, the disease has a 40% lifetime risk for sustaining a fragility fracture. [1] [2] [3] Type i osteoporosis, also known as postmenopausal osteoporosis, is characterized by increased bone turnover and accelerated cancellous bone loss, resulting in an increased risk of vertebral fractures. 3 Type ii osteoporosis affects both men and women and leads to an increased incidence of fractures; mortality and morbidity thus account for nearly three million disability-adjusted life years. Regardless of type, the underlying pathology of osteoporosis is aberrant bone turnover, secondary to imbalanced bone resorption and formation. 4 Bone disorders developed due to osteoporosis are often challenging to treat and therefore new techniques involving gene therapy, cell therapy, and tissue engineering are being explored to improve bone regeneration. 5 osteoporosis is a consequence of the imbalance between bone formation by the osteoblast and bone resorption carried out by the osteoclast, resulting in net bone loss. 6 The number of mesenchymal stem cells (MSCs) within bone marrow decreases with age and this may be associated with a reduction in bone formation. [7] [8] [9] [10] The number of MSCs, as well as their ability to differentiate into osteoprogenitor cells and mature osteoblasts, may be related to this imbalance. [11] [12] [13] [14] in addition to the differentiating ability of MSCs, their ability to mobilize from their niche to the tissue endothelium, and to mature into active cell types that modulate the fracture environment, is dependent upon their migration capacity. The stromal derived factor-1 (SDF-1) / C-X-C chemokine receptor type 4 (CXCR-4) axis has been found to be an important regulator of stem cell migration. SDF-1 is produced by a multitude of tissue types, including fracture endosteum, and in its active form is bound to the CXCR-4 receptor found on MSCs. Among others, Granero-Molto et al 15 have demonstrated that dynamic stem cell migration to the fracture site in a stabilized tibia osteotomy model was CXCR-4 dependent. The overexpression of CXCR-4 on mesenchymal stem cells led to significant increases in bone mineral density in an osteopenic mouse model, indicating the clinical significance of the SDF-1/CXCR-4 axis in the treatment of osteoporosis. The role of ageing and osteoporosis on CXCR-4 cell expression, and thus migration to SDF-1, is yet to be fully elucidated.
Although osteoporosis and ageing are interlinked, and differences between stem cells from young and old patients have been reported, no previous studies have compared the functional differences between MSCs from adolescent, adult, and osteoporotic populations. The aim of this study was to ovariectomize rats (ovX) and establish an osteopenic model, and to examine the influence of age and osteopenia on the morphology, proliferation, differentiation, CXCR-4 expression, and migration of bone marrow derived MSCs. The hypothesis was that MSCs from ovX rats will have a lower proliferative and osteogenic potential, will have a lower CXCR-4 expression and migratory capacity, and will be more likely to differentiate into adipocytes compared with MSCs obtained from young rats.
Materials and Methods
Bone marrow culture. Rat bone marrow mesenchymal stem cells (rBMCs) were harvested from randomized two-week-old to four-week-old, and six-month-old to nine-month-old, female Wistar rat femora (n = 6), with a mean lifespan of 22 months. 16 Bone marrow cells were harvested by flushing the femora with Dulbecco's modified Eagle medium (DMEM) (Sigma-Aldrich, St louis, Missouri), 20% fetal calf serum (Wolverhampton, United Kingdom), 1% penicillin streptomycin (Thermo Fisher Scientific, San Diego, California) in a 25 cm 2 flask. Cells were cultured at 37°C at 5% Co 2 . Media was changed after four days to remove non-adherent cells and then continuously refreshed twice a week thereafter. After ten to 14 days of primary culture and when the cells were between 70% and 80% confluent, they were passaged using Trypsin-EDTA (Sigma-Aldrich). rBMCs were passaged every seven to eight days. Cells were characterized by tridifferentation and phenotypically with immunocytochemistry. Rat ovariectomy. Wistar rats (n = 6) between six months and nine months old were weighed, anaesthetized, and shaved over the abdominal area. A transverse incision was made on the centre of the abdomen. The transverse abdominal muscles were exposed and dissected. Thereafter, the peritoneal space and adipose tissue surrounding the ovary were exposed. The ovary was then retracted, the area around the distal uterine horns was sutured to section it off, and the ovaries were removed. The procedure was then repeated on the left ovary through the same skin incision site. The rats were left for four months, after which their bone mineral density was measured using peripheral quantitative CT (pQCT) (Stratec XCT1000) and results were compared with nonovX control rats of the same age. Husbandry conditions for all animals were the same, whereby animals were housed in pairs in cages without restriction to ambulation on a standard rodent diet. Cages included adequate bedding and unrestricted access to fluids, along with objects for animal enrichment. The rats were then euthanized and stem cells isolated from their femora as described above.
Flow cytometry analysis for cluster of differentiation marker expression. A total of 10 000 rBMCs from young, adult control, and ovX rats were analyzed for their surface expression of cluster of differentiation (CD) CD29, CD90, CD45, and CD34. The cells were labelled with antimouse/rat CD29-fluorescein (Thermo Fisher Scientific), 17 anti-mouse/rat CD90-ApC (Thermo Fisher Scientific), antirat CD45-ApC (Thermo Fisher Scientific), and CD34-pE (Abcam, Cambridge, United Kingdom). The CD expression was compared with the isotype control. A total of 10 000 cells were fixed in 4% formalin for 15 minutes at room temperature, washed with 0.5% bovine serum albumin (BSA), and stained with the conjugated primary antibody for one hour at room temperature in the dark. After one hour, the cells were washed with 0.5% BSA and analyzed on flow cytometer (Cytoflex, Beckman Coulter, Brea, California). Cell morphology. passage 2 and 3 rBMCs from the three groups were cultured and their morphology was assessed by measuring their aspect ratio, whereby the ratio of the length of a cell to its width was calculated using imageJ software. 18 For each group, n = 3 was used. Cell proliferation. A total of 10 000 rBMCs from young, adult, and ovX rats (n = 3 for each group) were incubated in DMEM, 20% fetal calf serum, 1% penicillin streptomycin and 10% Alamar Blue assay (AbD Serotec, Kidlington, United Kingdom) for four hours; the resultant media was read at an excitation of 560 nm and an emission of 590 nm using a Tecan plate reader (infinite pro 200 Series, Tecan, Männedorf, Switzerland). The mean absorbance was determined from the triplicate samples. The absorbance was then normalized to the DNA assays and a comparison was made between the groups.
Osteogenic differentiation. A total of 30 000 cells from each of the three experimental groups were cultured in a 48-well plate in osteogenic media that consisted of DMEM supplemented with 100 nM dexamethasone, 50 ug/ml l-ascorbic acid 2-phosphate, and 10 mM betaglycerol phosphate (n = 3 from each group). The cells were grown at 37°C at 5% Co 2 and their alkaline phosphatase (Alp) activity was measured at three, seven, 14, and 21 days. This was then normalized against the DNA Hoescht assay (Sigma-Aldrich). Hoechst 33258 fluorimeteric dye (Sigma-14530, Sigma-Aldrich) was added to the cell lysates and fluorescence was measured at a wavelength of 460 nm. 19 Additionally, calcium phosphate deposition was measured by quantification of Alizarin Red staining using cetylpyridium chloride (CpC) on days seven, 14, and 21. The cells were washed in phosphate buffered saline (pBS), fixed in formalin for 15 minutes, and then stained with Alizarin Red solution (pH 4.2) for ten minutes at room temperature. The cultures were then rinsed five times with pBS. 20 The stained samples were photographed and then quantitatively de-stained using 10% CpC in 10 mM sodium phosphate, pH 7.0, for 15 minutes at room temperature. The Alizarin Red concentration was then read on a plate reader at a wavelength of 570 nm (infinite pro 200 Series, Tecan). Concentrations were determined using a standard curve obtained from tenfold serial dilutions of alizarin red. Adipogenic differentiation. A total of 30 000 cells were cultured in a 48-well plate in adipogenic media that consisted of DMEM supplemented with 0.1 mM dexamethasone, 50 mM indomethacin, 0.45 mM 3-isobutyl-1-methylxanthine, and 10 mg/ml insulin. The cells were grown at 37°C at 5% Co 2 and the presence of fat was stained using oil Red o at seven, 14, and 21 days. Additionally, oil Red o staining was quantified using 100% isopropanol. The cells were washed in pBS, fixed in paraformaldehyde for five minutes, washed with 60% isopropanol for ten minutes, and then stained with oil Red o solution for 15 minutes at room temperature. The cultures were then rinsed five times with pBS. The stained samples were photographed and then quantitatively destained using 100% isopropanol for 15 minutes at room temperature. The oil Red o concentration was read on a plate reader at a wavelength of 510 nm (infinite pro 200 Series, Tecan). Again, concentrations were determined using a standard curve obtained from tenfold serial dilution of oil Red o stain.
Flowcytometry analysis to measure CXCR-4 expression.
Young rBMCs from the third passage were trypsinized and centrifuged at 2000 rpm for ten minutes before 100 000 cells were resuspended in pBS. Cell aliquots were incubated with primary CXCR-4 antibody (Abcam) for 30 minutes at room temperature. The cells were washed in pBS and then incubated in secondary goat anti-rabbit antibody (Abcam) for 30 minutes at room temperature. The negative control consisted of cells incubated in the secondary antibody only. Then, 10 000 cells were analyzed using flow cytometry (Guava easyCyte system, Merck, Kenilworth, New Jersey). Cell migration. A chemoinvasion assay was used to evaluate the ability of rBMCs from young, adult, and ovX rats to migrate towards SDF-1. rBMCs from the three groups were loaded separately in serum free medium in upper compartments of the Boyden chamber, 5 µm pore size (Corning inc., Corning, New York). The lower compartment of the Boyden chamber was filled with 100 ng/ml SDF-1 (peprotech, london, United Kingdom) in DMEM and penicillin streptomycin. The chambers were incubated at 37°C, 5% Co 2 , for 16 hours to allow for cell migration through the chamber. After 16 hours, the cells that migrated to the opposite side of the membrane were fixed in 10% formaldehyde (Sigma-Aldrich) and stained with crystal violet (Sigma-Aldrich). The migrated cells were counted by selecting six random fields at ×20 magnification and calculating the percentage mean number of cells; the counter was blinded to the study group when analyzing the fields. For each cell type, the experiment was repeated in triplicate. For the control, both the top and bottom of the chamber were filled with normal media with no SDF-1 and the cells were loaded in the upper chamber as described. Statistical analysis. Data was analyzed using multiple twotailed Student's t-tests to make comparisons between specific groups. All data was compared using SpSS software (iBM inc., Armonk, New York); results were considered significant at p < 0.05 level and are expressed where appropriate with standard deviations.
Results
establishment of the rat osteopenic model. There were no surgical complications and no macroscopic signs of infection. At four months post-surgery, pQCT measurements demonstrated that the mean bone mineral density (BMD) of the ovX rats was 538.2 g/cm 3 (sd 23.3) in comparison to 666.9 g/cm 3 (sd 46) in aged matched rats, which was a reduction of 19.3% (sd 9) in BMD (p < 0.001). expression of CD markers. There was no mean significant difference in CD marker expression between rBMCs from young, adult control, and ovX rats. Flow cytometry showed high expression of CD29 (mean 95.1% (sd 3.2)), CD90 (mean 96.6% (sd 2.1)) and low expression of CD34 (mean 2.6% (sd 1.1)) and CD45 (mean 10.9% (sd 9.6)) for all three groups of MSCs. These CD marker expressions were similar for MSCs from all three groups of rats. Cell morphology. MSCs from young rats at passage 2 and 3 were smaller with more spindle-like features compared with MSCs from adult control and ovX rats. The mean aspect ratio measured in the young MSC group was 18.66 (sd 13.45), which was significantly larger than cells obtained from adult (mean 4.99 (sd 4.67)) and ovX rats (mean 2.25 (sd 0.94)).
Cell proliferation. Growth curves were plotted to examine cell proliferation. After three days in culture, the rBMCs showed time-dependent growth in all samples until day seven. overall, there was no significant difference in proliferation between rBMCs from young, adult control, and ovX rats. All cell groups had an increase in proliferation between days three and days seven (Fig. 1) .
Osteogenic differentiation. Mineralization of the extracellular matrix in young, adult, and ovX rBMCs increased significantly from day seven to day 21 for all the three rat groups (Fig. 2) . At day seven, the amount of calcium phosphate produced was similar between the three groups of cells, although by day 14 there was a significant increase in the amount of calcium phosphate produced by all groups; this remained the case up to day 21. At day 14, MSCs from young rats produced nearly three times the amount of mineral compared with cells isolated from ovariectomized animals (p = 0.004). This significant difference in mineralization (p = 0.0018) was still apparent at 21 days. When MSCs from young, adult, and ovX rats were differentiated to osteoblasts, there was a large variability in the Alp expression from day three to day 21 between the three groups of cells. in the young MSCs, the percentage change in Alp was seen to decrease from day three to day seven and increase thereafter up to day 14, after which it dropped significantly at day 21. However, this pattern was not visible for the adult control or ovX MSCs. The ovX MSCs had a peak increase in Alp expression at day seven and a drop at day 14. There was a significant difference in Alp change between young and ovX MSCs at day 14 (p = 0.003). However, due to the large variability in the Alp in adult MSCs, this significance was not observed between young and adult MSCs, or between adult and ovX MSCs (p = 0.21). it is worth noting that two of the adult MSC cultures at day 14 showed very low expression, whereas in one adult culture, the Alp expression was very high. interestingly, the Alp expression in the young stem cells cultures was less variable over all of the time periods studied. There was a percentage increase in Alp expression in ovX MSCs at day seven (mean 37.5% (sd 3.5), and this was significantly more than in young MSCs (p = 0.02). However, this surge in Alp was still not as high as that expressed by young MSCs at day 14 (mean 123% (sd 21.9) (Fig. 3) . Adipogenic differentiation. At days 14 and 21, adipocytic differentiation was significantly greater in MSCs isolated from young animals compared with adult control and ovX groups. MSCs from young rats formed lipid droplets significantly faster from day seven compared with the other two groups of cells. Additionally, lipid droplet accumulation significantly accelerated from day 14 to day 21 for young MSCs, while MSCs from adult and ovX rats showed no increase in lipid accumulation at days seven, 14, and, 21 (Fig. 4) . CXCR-4 expression. Flow cytometry results demonstrated that rBMCs from adult (p < 0.001) and ovX rats (p < 0.001) expressed significantly lower levels of CXCR-4 compared with rBMCs from young rats (Fig. 5) . The rBMCs from adult rats expressed significantly greater CXCR-4 in comparison with the ovX rats (p = 0.04). A mean of 32.1% (sd 6.2) and 19.4% (sd 9.8) of the rBMCS from adult and ovX rats expressed CXCR-4, respectively, while 87.5% (sd 5.1) of the young rBMCs expressed CXCR-4. Cell migration. The migration of SDF-1 doubled in the young cell group compared with adult rat cells (p = 0.023) and it was four times higher when compared with cells isolated from ovX rats (p = 0.013) (Fig. 6 ).
Discussion
impaired MSC recruitment from the stem cell niche, reduced differentiation to bone, and decreased proliferative activity of the mature stem cells are all probable causes of reduced bone formation in age-related disease. 21 our data has highlighted that during ageing and osteoporosis, the proliferative potential of the stem cells is maintained but their differentiation ability is compromised. Many studies have looked at the differences in stem cells from old and young animals; however, the novelty in this study includes comparing the stem cell function between young, adult control, and ovX rats. We have demonstrated differences between MSCs isolated from young, adult, and ovX rats; although all cells positively expressed CD90 and CD29 and negatively expressed CD45 and CD34, they showed differences in osteogenic and adipogenic differentiation potential. We also showed that the expression of CXCR-4 and migration of cells towards SDF-1 was much greater with cells derived from young rats, while cells isolated from ovX rats showed a reduction in migration compared with adult cells. The capability of cells to differentiate to bone and their use in cell-based therapy is vital in many orthopaedic interventions, particularly in the ageing population. There is contradictory data on the differentiation potential of MSCs from young and aged rats. With identifiable differences in gene expression, 22, 23 we had hypothesized that MSCs from ovX rats would have lower osteogenic potential and would more likely differentiate to adipocytes compared with MSCs from young rats; however, this was not the case. MSCs from ovX rats had lower osteogenic differentiation potential, but they also had a lower adipogenic differentiation ability compared with MSCs from young rats. Asumda and Chase 24 did not look at the differentiation potential of MSCs from osteopenic rats, but they showed similar differences to this study in terms of osteogenic and adipogenic differentiation between MSCs from young and old rats. They demonstrated a reduced differentiation ability of MSCs from old rats compared with MSCs from young rats. 24 However, Singh et al 25 found no observable difference in osteogenic and adipogenic differentiation between cells from young and old mice. likewise, Beane et al 26 showed no differences in Alp expression, as well as alizarin red staining, between bone marrow MSCs from young and old rabbits, but they found that age affected the adipogenic differentiation of the same cells. Moerman 27 reported changes in the expression of phenotype specific gene markers in bone marrow MSCs from older mice that encouraged them to differentiate to fat rather than bone in the bone marrow niche. Bone marrow from old mice had increased levels of peroxisome proliferator-activated receptor-gamme (ppAR-γ), which stimulated them to turn to fat rather than bone and inhibited osteoblast function. The bone marrow from the young mice, on the other hand, had increased levels of BMp-2 and TGF-β, which induced MSCs from these mice towards the osteoblastic lineage. our results were contrary to the main body of literature. For the reasons expressed above, previous studies have found increased adipogenic potential of cells gained from aged and/or osteopenic rats. Conversely, we found that the younger cells showed the greatest differentiating capacity of both the osteogenic and adipogenic lineage compared with the other cell groups. Such results demonstrate the importance of cell origin on differentiating capacity in addition to the cytokine profile in their environment. A further point of interest would be the comparison of ovariectomy in younger rats, comparing characteristics with agematched animals. This would remove the impact of ageing, and would enable one to look solely at the effect of osteopenia on cell activity. in the present study, there was no difference in proliferation between the different types of MSCs. This contrasts with other studies. Several studies have shown that MSCs from older rats have significantly lower proliferation compared with MSCs from young rats. 26, 28 Beane et al 26 looked at MSCs from young and old rabbits from the bone marrow, muscle, and fat; they demonstrated a relative reduction in proliferation with age of MSCs from the bone marrow, but not from the other two sources. Georgen 29 found that MSCs from ovX rats had a lower proliferation rate than their control counterparts and therefore concluded that the low proliferation rate would correlate with reduced self-renewal capacity, which might cause a gradual depletion of MSC sources in the bone marrow of ovX animals.
This study showed that MSCs from ovX rats have a lower in vitro migration and CXCR-4 expression compared with MSCs from young rats and control adult rats. This is in keeping with our previously published work on CXCR-4 transfection. 30 A study limitation may be in the method of flow cytometery for CXCR-4 analysis; if cells were not fully saturated with the primary antibody, levels of expression would not be representative. SDF-1 is a chemokine receptor for CXCR-4 and the SDF-1/CXCR-4 biological axis plays an important role in the migration of stem cells and the wound repair of tissues and organs. [31] [32] [33] [34] [35] The impaired migration capacity of MSCs from four months post-ovariectomy rats could be due to their low expression of CXCR-4; this could explain the impaired bone formation in osteoporotic patients, as cells from these patients have a reduced capacity to migrate to the site of bone loss. SDF-1 is produced in the periosteum of injured bone and encourages endochondral bone repair by recruiting mesenchymal stem cells to the site of injury. Therefore, mobilization of osteoblastic progenitors to the bone surface is an important step in osteoblast maturation and formation of mineralized tissue. 36 This study supports the notion that, although stem cells remain active with age, their differentiation ability is affected, therefore impairing their regenerative and differentiation capacity. The contradictory results from various studies could be because of variability of patients, osteoporotic models, and sources of stem cells. Further animal studies are necessary to clarify whether the in vivo bioactivity of MSCs from young patients is good enough for bone regeneration in osteoporotic patients, and whether using cells from younger hosts could be an option for cellular and genetic therapies for bone degenerative diseases. There are other factors to consider as well in such stem cell therapies; for example, would an allogenic stem cell source from young patients be compatible in osteoporotic patients? Although we have shown that stem cells from ovX rats are similar in their proliferation and expression of CD markers to their younger counterparts, their inability to migrate to the site of bone loss, as well as their reduced capacity to differentiate, renders them incompetent to form bone. in addition, the rat ovX model is an osteopenic model and does not fully represent human osteoporosis. This study could therefore be further validated by using MSCs from human osteoporotic, agematched non-osteoporotic, and young patients.
